Screen for autism
1
2 3

The diagnosis of ASD isn't made on every person suspected, and sometimes a definitive diagnosis may not be made immediately - for both logistic and scientific reasons. While the suggestion that a person may have ASD is often painful for all concerned, it's far better to mention this as a possible diagnosis than to offer superficial reassurance. Most families of individuals with (and without) ASD will already have thought about this possibility, and many report having tried for some time to obtain a referral for more definitive testing.

How is ASD diagnosed?
See Table 3 for the definitive assessment of a person with possible ASD. This kind of comprehensive approach requires a variety of professionals from different backgrounds who ideally have a good working relationship. Some "teams" may see the patient in different places and times and communicate from a distance; in this situation, one person becomes responsible for integrating and interpreting the results of others. School-aged children may have access to a few of the above assessments through the education system, and input from healthcare professionals is required to complete their evaluation. Some of the information needed to sort out the differential may indeed only be available to a general practitioner, such as the family circumstances leading to reactive attachment disorder.

Individuals with typical, severe autism may be "untestable" on standardized tests and extensive assessment may not be necessary to establish their diagnosis. Milder, less typical forms of ASD require more careful evaluation, and young children may need several over time in order to reach a confident diagnosis. This can be difficult for parents looking for intervention, since funding agencies often withhold approval for such programs if there's no clear diagnosis. It's often tempting to offer a more confident diagnosis than the data support in order to get kids into intervention programs, but this approach leads to trouble later on.

One of the major issues in ASD diagnosis is that "neurotypicals," i.e. those of us without ASD, have a range of social communication abilities, and we don't use our skills all the time. While social communication can be precisely measured using research-standard instruments such as the ADOS, in many clinical settings less formal measures (such as the assessor's own ability to interact) are used. People "near the edge of the spectrum" may look more or less functional depending on the environment, so these informal measures are less reliable.

What are the treatment options?
As soon as possible (and often before the diagnosis is fully established), individuals with ASD should begin to work on communication enhancement, behaviour management and family support. The long-term goal of ASD intervention is not to cure the person, but to achieve "optimal functioning." All people with ASD should participate in group learning settings to the extent that they can do so successfully; for some, this may mean a severely restricted setting, while others require only minimal support in order to be integrated with typical peers. The main place that provides group learning opportunities for children is the education system, and this is also the primary location for intervention. Extensive intervention programs such as Applied Behavioral Analysis (ABA) or Intensive Behavioral Intervention (IBI) are also now provided in the family home; they're typically funded through social service agencies, though this varies by jurisdiction.

While there's no specific medication indicated for the treatment of ASD, most people with this diagnosis end up on at least one chronic medication by adulthood; frequently they'll be taking multiple meds, and often these are neuroleptics. The drugs may be prescribed to treat specific target symptoms, for instance sleep disturbances, inattention or impulsivity, obsession or other anxieties, depression or seizures - or they may be for nonspecific problems such as "emotional dysregulation." While medication shouldn't be used as a substitute for good programming and support, it can certainly enhance the effectiveness of interventions (and help retain the support staff) when used appropriately.

For various reasons, individuals with ASD are often treated with a range of alternative therapies. While few of these are actually dangerous, almost none of them have been evaluated, and some have a considerable cost to the family. The potential for guilt trips on the parents' side is also of concern, since many of these "therapies" are very difficult to administer to a person with limited social communication abilities, mistrust of novelty, and sensory hypersensitivities.

Where does the GP fit in?
The primary care physician is involved in many aspects of the care of individuals with ASD and their families. Screening and surveillance are critical, particularly for very young children and adults. Also, families often need support during the time of diagnosis, both to deal with the emotional issues and to gain access to services. Once someone has been diagnosed, they require ongoing care - both for the ASD and for any additional illnesses.

GPs are often the only source of prescribing assistance available and may have lots of experience with some of the target symptoms mentioned. While individuals with ASD may be more sensitive to side effects than others, they usually respond well to the same medications if one "starts low and goes slow." Another obstacle, however, is the resistance to change: the same family that fights the initiation of a medication for months or years may then become extremely reluctant to discontinue it. Support from a family physician is helpful in this.

Adults with ASD face many challenges, not the least of which is that specialist care for ASD is mostly found through pediatricians or child psychiatrists. It's important to have a "developmental" perspective into young adulthood; those of us with young adult offspring know that adolescence doesn't end at 18 - even for neurotypicals. Also, the long-term side effects of medications such as neuroleptics begin to show up later in life. Another difficulty that arises from the transition to adulthood is the problem of aging caregivers and the fact that siblings start to have families of their own. This is yet another "growth opportunity" for family practice.

 

1
2 3

 

 

 

References:

  1. Johnson CP et al. Pediatrics 2007;120: 1183-215.
  2. Johnson CP et al. Pediatrics 2007;120: 1162-82.
  3. Barbaresi WJ et al. Arch Pediatr Adolesc Med 2006;160:1167-75.
  4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition Text Revision. Washington, DC. American Psychiatric Association, 2000.
  5. Grandin, Temple. Thinking in pictures: and Other Reports from My Life with Autism. Vintage Books, 1996.
  6. Klauck SM. Eur J Human Genet 2006;14:714-20.
  7. Zwaigenbaum L et al. Int J Dev Neurosci 2005;23:143-52.
  8. Glascoe FP. Parents Evaluation of Developmental Status (PEDS). Nashville, Tennessee. Ellsworth & Vandermeer Press, 2006. Also check out www.pedstest.com.
  9. Wetherby AM et al. J Autism Dev Disord 2004;3 4:473-93.
  10. Robins D et al. J Autism Dev Disord 2001;31:131-44.
  11. Filipek PA et al. Neurology 2000; 55:468-79.

 

 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
Site created by Spin Design T. (514) 995-4398